Baccarani U, Carroll B J, Hiatt J R, Donini A, Terrosu G, Decker R, Chandra M, Bresadola F, Phillips E H
Department of Surgery, University of Udine, Italy.
Arch Surg. 1998 May;133(5):517-21; discussion 521-2. doi: 10.1001/archsurg.133.5.517.
Staging laparotomy provides useful information for management of Hodgkin disease but has fallen into disfavor because procedure-related morbidity exceeds that of new chemotherapeutic regimens.
To determine the feasibility, effectiveness, and safety of laparoscopic staging for Hodgkin disease compared with those of open staging.
Fifty-five patients with Hodgkin disease of cell types including nodular sclerosis in 43 (78%), mixed cellularity in 9 (16%), and lymphocyte predominance in 3 (5%).
Concurrent evaluation of laparoscopic staging (n = 15) and retrospective review of open staging (n = 40).
Laparoscopic and open techniques of surgical staging for Hodgkin disease, including splenectomy, liver biopsies, and lymph node sampling.
Operative time, duration of postoperative ileus and of postoperative hospitalization, morbidity, number of lymph nodes retrieved, alteration in pathologic stage, recurrence, and survival.
For laparoscopic staging vs open staging groups, mean operative time was 202 vs 144 minutes (P=.001); mean postoperative ileus was 1.9 vs 3.2 days (P<.001); mean postoperative hospitalization was 4.4 vs 6.7 days (P<.001); complications occurred in 3 patients (20%) vs 11 patients (28%) (P=.57); and mean number of lymph nodes retrieved was 8.5 vs 4.6 (P=.05). In the laparoscopic staging group, 2 cases (13%) were upstaged and 2 cases (13%) were downstaged. In the open staging group, 6 cases (15%) were upstaged and 3 cases (7.5%) were downstaged. Follow-up data were available for all patients in the laparoscopic staging group, at a mean of 23.5 months postoperatively. All were alive, none had recurrent disease below the diaphragm, and 2 (13%) had residual mediastinal disease. Follow-up data were available for 31 patients (78%) in the open staging group at a mean of 52.5 months postoperatively. All were alive, 27 (87%) were disease free, 3 (10%) had had relapses above the diaphragm, and 1 (3%) had residual mediastinal disease.
Compared with open staging, laparoscopic staging of Hodgkin disease is oncologically equivalent and functionally superior. These data should encourage reappraisal of the role of operative staging in the management of Hodgkin disease.
分期剖腹术可为霍奇金淋巴瘤的治疗提供有用信息,但由于与手术相关的发病率超过了新的化疗方案,已不再受到青睐。
比较腹腔镜分期与开放分期用于霍奇金淋巴瘤分期的可行性、有效性和安全性。
55例霍奇金淋巴瘤患者,细胞类型包括结节硬化型43例(78%)、混合细胞型9例(16%)和淋巴细胞为主型3例(5%)。
对腹腔镜分期(n = 15)进行同期评估,并对开放分期(n = 40)进行回顾性分析。
霍奇金淋巴瘤的腹腔镜和开放手术分期技术,包括脾切除术、肝活检和淋巴结取样。
手术时间、术后肠梗阻持续时间和术后住院时间、发病率、获取的淋巴结数量、病理分期改变、复发情况和生存率。
腹腔镜分期组与开放分期组相比,平均手术时间分别为202分钟和144分钟(P = 0.001);平均术后肠梗阻时间分别为1.9天和3.2天(P < 0.001);平均术后住院时间分别为4.4天和6.7天(P < 0.001);并发症发生情况分别为3例(20%)和11例(28%)(P = 0.57);平均获取的淋巴结数量分别为8.5个和4.6个(P = 0.05)。在腹腔镜分期组中,2例(13%)分期上调,2例(13%)分期下调。在开放分期组中,6例(15%)分期上调,3例(7.5%)分期下调。腹腔镜分期组所有患者均有随访数据,术后平均随访23.5个月。所有患者均存活,无一例在横膈以下复发,2例(13%)有纵隔残留病灶。开放分期组31例(78%)患者有随访数据,术后平均随访52.5个月。所有患者均存活,27例(87%)无疾病,3例(10%)在横膈以上复发,1例(3%)有纵隔残留病灶。
与开放分期相比,霍奇金淋巴瘤的腹腔镜分期在肿瘤学上等效且功能上更优。这些数据应促使重新评估手术分期在霍奇金淋巴瘤治疗中的作用。